Author:
Hassel J.C.,Livingstone E.,Allam J.P.,Behre H.M.,Bojunga J.,Klein H.H.,Landsberg J.,Nawroth F.,Schüring A.,Susok L.,Thoms K.M.,Kiesel L.,Berking C.
Reference76 articles.
1. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study;Abate;JAMA Oncol,2019
2. Melanoma;Schadendorf;Lancet,2018
3. Survival of patients with advanced metastatic melanoma: the impact of MAP kinase pathway inhibition and immune checkpoint inhibition—Update 2019;Ugurel;Eur J Cancer,2020
4. Adjuvant pembrolizumab versus placebo in resected stage III melanoma;Eggermont;N Engl J Med,2018
5. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma;Weber;N Engl J Med,2017
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献